Michael G M Derks (Michael Derks)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Attention Deficit Hyperactivity Disorder

Acute Ischemic Stroke

Top Venues

Journal of pharmacokinetics and pharmacodynamics

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Franziska Schaedeli Stark, Clarisse Chavanne, Michael G M Derks, Koen Jolling, Hendrik Maxime Lagraauw, Lars Lindbom, Klaas Prins, Hanna E Silber Baumann
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations. Journal of pharmacokinetics and pharmacodynamics 51 (3) (2024)
Franziska Schaedeli Stark, Clarisse Chavanne, Michael G M Derks, Koen Jolling, Hendrik Maxime Lagraauw, Lars Lindbom, Klaas Prins, Hanna E Silber Baumann
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations. Journal of pharmacokinetics and pharmacodynamics 51 (3) (2024)
Franziska Schaedeli Stark, Clarisse Chavanne, Michael G M Derks, Koen Jolling, Hendrik Maxime Lagraauw, Lars Lindbom, Klaas Prins, Hanna E Silber Baumann
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations. Journal of pharmacokinetics and pharmacodynamics 51 (3) (2024)
Franziska Schaedeli Stark, Clarisse Chavanne, Michael G M Derks, Koen Jolling, Hendrik Maxime Lagraauw, Lars Lindbom, Klaas Prins, Hanna E Silber Baumann
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations. Journal of pharmacokinetics and pharmacodynamics 51 (3) (2024)
Franziska Schaedeli Stark, Clarisse Chavanne, Michael G M Derks, Koen Jolling, Hendrik Maxime Lagraauw, Lars Lindbom, Klaas Prins, Hanna E Silber Baumann
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations. Journal of pharmacokinetics and pharmacodynamics (2024)
Michael G M Derks, Christoph Wandel, Annie Young, Stuart K Bolt, Christoph Meyenberg
Open-Label Assessment of the Effects of Itraconazole and Rifampicin on Balovaptan Pharmacokinetics in Healthy Volunteers. Advances in therapy 37 (11) (2020)